$OCUL·4

OCULAR THERAPEUTIX, INC · Feb 10, 4:34 PM ET

OCULAR THERAPEUTIX, INC 4

4 · OCULAR THERAPEUTIX, INC · Filed Feb 10, 2017

Insider Transaction Report

Form 4
Period: 2017-01-31
Sawhney Amarpreet
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-01-31+235,000235,000 total
    Exercise: $6.56Exp: 2027-01-30Common Stock (235,000 underlying)
Footnotes (1)
  • [F1]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION